GPI Pulse - Global Pricing Innovations Indication-Level Treatment Costs - Pharma Data

GPI pulse™ is a dynamic value, price, and access analytics platform, utilising powerful algorithms to combine multiple data streams in a way that will give you unique insight into the full market access journey. This powerful platform is designed to be used as part of GPI’s comprehensive solution for pricing and market access strategy, but can also be leveraged to rapidly extract customised sets of analysis-ready data. In addition to the drug-level price and reimbursement data, GPI pulse™ also offers indication-level treatment costs for a more granular view. This additional layer allows for standardised comparison of cost to treat a patient (per day/moth/annum) across markets and by specific indication. This indication-level data requires further calculations that consider the posology. For this reason, regulatory label approval data are incorporated to provide an accurate picture of the treatment costs per patient in each market. Use cases: - Understand the difference in cost to treat a patient by indication in a particular market - Compare the cost to treat a patient in different markets of interest - Standardised comparisons of the cost to treat a patient with different therapies - Visualise historical price evolution GPI continually invest in technology, taxonomy, and quality assurance, to ensure our data is the gold-standard in terms of accuracy, granularity, and timeliness. GPI pulse™ supports the full spectrum of biopharma clients, from top tier pharma to clinical stage biotech. The analytics tools within GPI pulse™ are built specifically with pricing, market access, and commercial strategy teams in mind. FREE DATA SAMPLES AVAILABLE: - Pricing - Cost of Treatment - Reimbursement and HTAGPI pulse™ 是一款动态价值、定价与市场准入（Market Access）分析平台，依托强大算法整合多源数据流，可助力用户全面洞悉完整的市场准入全流程。 这款高性能平台既可作为GPI全套定价与市场准入战略解决方案的组成部分投入使用，也可快速提取定制化的分析就绪数据集。 除药物层级的价格与医保报销数据外，GPI pulse™ 还提供适应症（Indication）层级的治疗成本数据，以实现更精细的洞察视角。该额外数据层级支持跨市场及特定适应症下的患者治疗成本标准化对比，统计维度涵盖每日、每月及每年。 该适应症层级数据需结合给药方案（Posology）开展进一步计算。为此，平台纳入了监管标签获批数据，以精准呈现各市场内每位患者的治疗成本。 用例： - 了解特定市场内不同适应症对应的患者治疗成本差异 - 对比目标市场间的患者治疗成本 - 不同疗法对应的患者治疗成本标准化对比 - 可视化展示历史价格走势 GPI持续投入技术研发、分类体系（Taxonomy）建设与质量管控，以确保我们的数据在准确性、精细化程度与时效性方面均达到行业金标准。 GPI pulse™ 服务覆盖全品类生物制药客户，从顶级制药企业到临床阶段的生物技术公司均可适配。 GPI pulse™ 内置的分析工具专为定价、市场准入与商业战略团队定制开发。 免费数据样本可获取： - 定价数据 - 治疗成本数据 - 医保报销与卫生技术评估（Health Technology Assessment, HTA）

搜集汇总

背景与挑战

背景概述

GPI pulse™是一个动态的价值、定价和市场准入分析平台，通过算法整合多数据流，提供全球药品定价、报销及适应症层面的治疗成本信息。该平台支持标准化比较不同市场和适应症的患者治疗成本，并专为定价、市场准入和商业策略团队设计，确保数据在准确性、颗粒度和及时性方面达到高标准。